Too many roads not taken

@article{Edwards2011TooMR,
  title={Too many roads not taken},
  author={Aled M. Edwards and Ruth Isserlin and Gary D Bader and Stephen V. Frye and Timothy Mark Willson and Frank H Yu},
  journal={Nature},
  year={2011},
  volume={470},
  pages={163-165}
}
Most protein research focuses on those known before the human genome was mapped. Work on the slew discovered since, urge Aled M. Edwards and his colleagues. 

Figures from this paper

Prioritizing Proteomics Assay Development for Clinical Translation.
Priorities and trends in the study of proteins in eye research, 1924–2014
TLDR
To identify the proteins that are relevant to eye research and develop assays for the study of a set of these proteins, a database of more than 1,000 proteins was developed.
Too Many Roads Not Taken in Biomarker Discovery: The Story of Missing Tools
The draft sequence of the human genome was completed in 2000, and scientists, funding agencies, and industry all claimed at the time that this groundbreaking accomplishment would translate into
Integration of RNA and protein expression profiles to study human cells
TLDR
The objective of this study was to demonstrate the ability to characterize the response of the immune system to foreign substances such as chemotherapy and radiation to treat central nervous system disorders.
Epitope mapping of antibodies towards human protein targets
This thesis, based on five research papers, presents results from development and evaluation ofmethods for identifying the interaction site of antibodies on their antigens and the functional invest
How much research is spurred when a gene is associated with a complex disease
TLDR
GWAS have not changed the historical skew of publications toward genes involved in Mendelian diseases, but genes newly implicated by GWAS in complex disease do experience a modest increase in publication activity.
Calling the next generation of affinity reagents
TLDR
As complements to antibodies, new reagents to target proteins invite broad types of experiments and can be used in a wide range of experiments to improve the quality of research.
Probing the epigenome.
TLDR
Systematic coverage of emerging epigenetic target classes with these potent, selective, cell-active chemical tools will profoundly influence understanding of the human biology and pathology of chromatin-templated mechanisms.
Human genes : Time to follow the roads less traveled ?
TLDR
The factors that explain this bias in the amount of attention the research community gives to each of the more than 20,000 human genes are uncovered and a way ahead is offered to move more genes into the research limelight.
Dynamics of the discovery process of protein-protein interactions from low content studies
TLDR
This model strongly suggests that research focus biases exist in the observed discovery dynamics of these networks, and more care should be placed when using PPIN databases for analysis of newly acquired data, and when considering prior knowledge when designing new experiments.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 31 REFERENCES
The (un)targeted cancer kinome.
The complexity of cancer signaling and the resulting difficulties in target selection have strongly biased kinase drug discovery towards clinically validated targets. Recently, novel kinase targets
The art of the chemical probe.
  • S. Frye
  • Biology, Chemistry
    Nature chemical biology
  • 2010
TLDR
A set of principles to guide probe qualification is proposed, which aim to create small-molecule probes that interact with a specific protein in vitro in order to explore the role of the protein in a broader biological context.
The Protein Kinase Complement of the Human Genome
TLDR
The protein kinase complement of the human genome is catalogued using public and proprietary genomic, complementary DNA, and expressed sequence tag sequences to provide a starting point for comprehensive analysis of protein phosphorylation in normal and disease states and a detailed view of the current state of human genome analysis through a focus on one large gene family.
Identification of Ligands for the Orphan Nuclear Receptor GCNF
TLDR
HTS has been executed with a luciferase reporter assay in CHO cells stably expressing an ERa/GCNF chimer and GCNF binding of agonists and antagonists was confirmed by GCNF/cofactor interactions studies in solution.
Genomics versus orphan nuclear receptors--a half-time report.
TLDR
The significant progress that has been made in the functional analysis of more than half of the nuclear receptor gene family provides an opportunity to review the impact of genomics in this endeavor.
Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ.
TLDR
This work has identified the first synthetic RORα/γ agonist, SR1078, and this compound can be utilized as a chemical tool to probe the function of these receptors both in vitro and in vivo.
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
TLDR
The identification of two homozygous mutations affecting the PINK1 kinase domain in three consanguineous PARK6 families provide a direct molecular link between mitochondria and the pathogenesis of PD.
Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha.
TLDR
The discovery of the first potent and selective inverse agonist of ERR alpha is described, which will elucidate the endocrine signaling pathways mediated by ERRalpha including association with human disease states.
...
1
2
3
4
...